中交(01800.HK)附屬斥3.24億人幣成立項目公司
中國交通建設(01800.HK)公布,為共同投資武漢長江新城起步區基礎設施工程PPP項目,公司附屬二航局,及中國城鄉、碧水源、中鐵十八局、長江新城建投、中信建設及信恆銀通訂立股東合同。
根據相關合同,項目公司的註冊資本約為15.96億元人民幣(下同),其中信恆銀通、二航局、中信建設及長江新城建投將分別出資約9.84億元、3.24億元、1.92億元、4,800萬元,分別佔項目公司註冊資本總額的61.67%、20.33%、12%及3%。另外中國城鄉、碧水源及中鐵十八局各出資1,600萬元,各佔1%。其中中國城鄉及碧水源為公司控股股東附屬。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.